Treatment of severe hypertension during pregnancy: we still do not know what the best option is (2020)
- Authors:
- Autor USP: COSTA, FABRICIO DA SILVA - FMRP
- Unidade: FMRP
- DOI: 10.1080/10641955.2019.1708383
- Subjects: FÁRMACOS (SISTEMA CARDIOVASCULAR); MEDICAMENTO; HIPERTENSÃO NA GRAVIDEZ; FARMACOTERAPIA; ÍNDICE DE GRAVIDADE DA DOENÇA; ACIDENTE VASCULAR CEREBRAL; RESULTADO DE TRATAMENTO
- Keywords: Severe hypertension in pregnancy; Key outcome parameters; Target blood pressure; Pre-eclampsia; Maternal and perinatal morbidity
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: Philadelphia
- Date published: 2020
- Source:
- Título do periódico: Hypertension in Pregnancy
- ISSN: 1064-1955
- Volume/Número/Paginação/Ano: v. 39, n. 1, p. 25-32, 2020
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
WERTASCHNIGG, Dagmar et al. Treatment of severe hypertension during pregnancy: we still do not know what the best option is. Hypertension in Pregnancy, v. 39, n. 1, p. 25-32, 2020Tradução . . Disponível em: https://doi.org/10.1080/10641955.2019.1708383. Acesso em: 30 set. 2024. -
APA
Wertaschnigg, D., Wang, R., Reddy, M., Costa, F. da S., Mol, B. W., & Rolnik, D. L. (2020). Treatment of severe hypertension during pregnancy: we still do not know what the best option is. Hypertension in Pregnancy, 39( 1), 25-32. doi:10.1080/10641955.2019.1708383 -
NLM
Wertaschnigg D, Wang R, Reddy M, Costa F da S, Mol BW, Rolnik DL. Treatment of severe hypertension during pregnancy: we still do not know what the best option is [Internet]. Hypertension in Pregnancy. 2020 ; 39( 1): 25-32.[citado 2024 set. 30 ] Available from: https://doi.org/10.1080/10641955.2019.1708383 -
Vancouver
Wertaschnigg D, Wang R, Reddy M, Costa F da S, Mol BW, Rolnik DL. Treatment of severe hypertension during pregnancy: we still do not know what the best option is [Internet]. Hypertension in Pregnancy. 2020 ; 39( 1): 25-32.[citado 2024 set. 30 ] Available from: https://doi.org/10.1080/10641955.2019.1708383 - Assessing peristalsis at the endometrial–myometrial junctional zone: a reproducible ultrasound technique?
- Outcomes following the detection of fetal edema in early pregnancy prior to non‐invasive prenatal testing
- A minimum estimate of the prevalence of 22q11 deletion syndrome and other chromosome abnormalities in a combined prenatal and postnatal cohort
- External validation of prognostic models predicting pre-eclampsia: individual participant data meta-analysis
- Second‐ and third‐trimester serum levels of growth‐differentiation factor‐15 in prediction of pre‐eclampsia
- Challenging the definition of hypertension in pregnancy: a retrospective cohort study
- A randomised controlled trial to assess the feasibility of utilising virtual reality to facilitate analgesia during external cephalic version
- The importance of ultrasound preceding cell‐free DNA screening for fetal chromosomal abnormalities
- Ultrasound appearances of the acrania‐anencephaly sequence at 10 to 14 weeks’ gestation
- Serum leukotriene B4 and hydroxyeicosatetraenoic acid in the prediction of pre-eclampsia
Informações sobre o DOI: 10.1080/10641955.2019.1708383 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 | 003176680.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
